
Impairment of IFN-α production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma
Author(s) -
Kazuko Uno,
Yoshiki Suginoshita,
Kazuhiro Kakimi,
Fuminori Moriyasu,
Mayumi Hirosaki,
Taro Shirakawa,
Tsunataro Kíshida
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i46.7330
Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , sendai virus , hepatitis c virus , gastroenterology , hepatitis c , interferon , liver disease , virus , hepatitis b virus , immunology
To determine the utility of interferon (IFN)-alpha production capacity in patients with hepatitis C virus (HCV) infection for the measurement of immuno-surveillance potential and for the early detection of hepatocellular carcinoma (HCC) by investigating the Sendai virus (HVJ) stimulated IFN-alpha production capacity of patients with HCV infection.